the ability— looks as though they restore some of the ability to actually reduce infection, probably quite a lot of it actually, at least for a period of time. — it actually, at least for a period of time, and so there are multiple reasons— of time, and so there are multiple reasons to — of time, and so there are multiple reasons to get the booster. it will reduce _ reasons to get the booster. it will reduce a — reasons to get the booster. it will reduce a risk of severity, it will reduce — reduce a risk of severity, it will reduce the _ reduce a risk of severity, it will reduce the risk of mortality and almost — reduce the risk of mortality and almost certainly reduce the risk of transmitting and getting symptomatic disease _ transmitting and getting symptomatic disease. we really want to push the point _ disease. we really want to push the point that— disease. we really want to push the point that booster is critical to theirs — point that booster is critical to theirs. ~ ., ., theirs. when will we get good data on hospitalisation _ theirs. when will we get good data on hospitalisation rates _ theirs. when will we get good data on hospitalisation rates and - theirs. when will we get good data on hospitalisation rates and risk i theirs. when will we get good data on hospitalisation rates and risk of| on hospitalisation rates and risk of severe illness and death? fate on hospitalisation rates and risk of severe illness and death?- severe illness and death? we will aet severe illness and death? we will get reasonable _ severe illness and death? we will get reasonable data _ severe illness and death? we will get reasonable data from - severe illness and death? we will get reasonable data from south l get reasonable data from south africa _ get reasonable data from south africa before the uk, but that will be for _ africa before the uk, but that will be for two — africa before the uk, but that will be for two doses because they haven't— be for two doses because they haven't got a booster programme in the way— haven't got a booster programme in the way we — haven't got a booster programme in the way we have yet. they will go first on _ the way we have yet. they will go first on the — the way we have yet. they will go first on the clinical side but there is good _ first on the clinical side but there is good data coming here and i will ask doctor— is good data coming here and i will ask doctor hopkins to talk about that because they say... they are leading _ that because they say... they are leading on— that because they say... they are leading on this. in terms of the booster— leading on this. in terms of the booster that would take longer